The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications
Open accessAbstract
Gut microbiota dysregulation plays a key role in the pathogenesis of nonalcoholic fatty liver disease (NAFLD) through its metabolites. Therefore, the restoration of the gut microbiota and supplementation with commensal bacterial metabolites can be of therapeutic benefit against the disease. In this review, we summarize the roles of various bacterial metabolites in the pathogenesis of NAFLD and their therapeutic implications. The gut microbiota dysregulation is a feature of NAFLD, and the signatures of gut microbiota are associated with the severity of the disease through altered bacterial metabolites. Disturbance of bile acid metabolism leads to underactivation of bile acid receptors FXR and TGR5, causal for decreased energy expenditure, increased lipogenesis, increased bile acid synthesis and increased macrophage activity. Decreased production of butyrate results in increased intestinal inflammation, increased gut permeability, endotoxemia and systemic inflammation. Dysregulation of amino acids and choline also contributes to lipid accumulation and to a chronic inflammatory status. In some NAFLD patients, overproduction of ethanol produced by bacteria is responsible for hepatic inflammation. Many approaches including probiotics, prebiotics, synbiotics, faecal microbiome transplantation and a fasting-mimicking diet have been applied to restore the gut microbiota for the improvement of NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
Agus, A., Planchais, J., & Sokol, H. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.05.003 · Cited by 3,180 · cited 1×
“There r three metabolic pathways that commensal bacteria in the gut use to metab lize tryptophan (Figure 3) [45].”
BackgroundVrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R. S., Bartelsman, J. F. W. M., Dallinga–Thie, G. M., Ackermans, M. T., Serlie, M. J., Oozeer, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.031 · Cited by 2,913
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., Sato, H., Messaddeq, N., Harney, J. W., Ezaki, O., Kodama, T., et al. (2006) · Nature · doi:10.1038/nature04330 · Cited by 2,220
Human gut microbes impact host serum metabolome and insulin sensitivity
Pedersen, H. K., Gudmundsdottir, V., Nielsen, H. B., Hyotylainen, T., Nielsen, T., Jensen, B. A. H., Forslund, K., Hildebrand, F., Prifti, E., Falony, G., et al. (2016) · Nature · doi:10.1038/nature18646 · Cited by 2,116 · cited 2×
“(2016) found that increased BCAA levels were consistent with enhanced biosynthetic potential for BCAAs by the gut microbiota [63].”
BackgroundZhu, L., Baker, S. S., Gill, C., Liu, W., Alkhouri, R., Baker, R. D., & Gill, S. R. (2013) · Hepatology · doi:10.1002/hep.26093 · Cited by 1,708 · cited 2×
“(2013) studied the endogenous production of ethanol in the gut in NAFLD and observed high increased ethanol levels in NASH patients compared to healthy subjects or in obese non-NASH patients [67].”
BackgroundBoursier, J., Mueller, O., Barret, M., Machado, M., Fizanne, L., Araujo‐Perez, F., Guy, C. D., Seed, P. C., Rawls, J. F., David, L. A., et al. (2016) · Hepatology · doi:10.1002/hep.28356 · Cited by 1,483 · cited 2×
“Compared to steatosis, the gut microbiome associated with NASH presents with a higher abundance of Bacteroides than that with fibrosis that presents with significantly increased Ruminococcus [8].”
BackgroundBranched-chain amino acids in metabolic signalling and insulin resistance
Lynch, C. J., & Adams, S. H. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.171 · Cited by 1,461
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
Aron-Wisnewsky, J., Vigliotti, C., Witjes, J., Le, P., Holleboom, A. G., Verheij, J., Nieuwdorp, M., & Clément, K. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0269-9 · Cited by 1,063
The role of the gut microbiota in NAFLD
Leung, C., Rivera, L., Furness, J. B., & Angus, P. W. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.85 · Cited by 1,020 · cited 2×
“Acetate and propionate also have anti-inflammatory effect, however, these two SCFAs can promote lipid accumulation and gluconeogenesis in the liver [44], therefore, they are unlikely to be used for NAFLD therapy.”
BackgroundIntestinal microbiota determines development of non-alcoholic fatty liver disease in mice
Le Roy, T., Llopis, M., Lepage, P., Bruneau, A., Rabot, S., Bevilacqua, C., Martin, P., Philippe, C., Walker, F., Bado, A., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-303816 · Cited by 1,001
(1958) · PubMed · Cited by 978
Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women
Hoyles, L., Fernández-Real, J.-M., Federici, M., Serino, M., Abbott, J., Charpentier, J., Heymes, C., Luque, J. L., Anthony, E., Barton, R. H., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0061-3 · Cited by 720 · cited 7×
“(2018) showed that transplantation of a steatosis-associated microbiome into mice increased hepatic triglycerides and circulating branched chain amino acids and trimethylamine N-oxide (TMAO) [16].”
BackgroundInfluentialTGR5 Activation Inhibits Atherosclerosis by Reducing Macrophage Inflammation and Lipid Loading
Pols, T. W. H., Nomura, M., Harach, T., Lo Sasso, G., Oosterveer, M. H., Thomas, C., Rizzo, G., Gioiello, A., Adorini, L., Pellicciari, R., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.11.006 · Cited by 610
Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy
Chiang, J. Y. L., & Ferrell, J. M. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00223.2019 · Cited by 580
Tomlinson, E., Fu, L., John, L., Hultgren, B., Huang, X., Renz, M., Stephan, J. P., Tsai, S. P., Powell-Braxton, L., French, D., et al. (2002) · Endocrinology · doi:10.1210/endo.143.5.8850 · Cited by 576
Wei, M., Brandhorst, S., Shelehchi, M., Mirzaei, H., Cheng, C. W., Budniak, J., Groshen, S., Mack, W. J., Guen, E., Di Biase, S., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aai8700 · Cited by 553
Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella Pneumoniae
Yuan, J., Chen, C., Cui, J., Lu, J., Yan, C., Wei, X., Zhao, X., Li, N., Li, S., Xue, G., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.018 · Cited by 548
Non-alcoholic fatty liver disease and diabetes
Hazlehurst, J. M., Woods, C., Marjot, T., Cobbold, J. F., & Tomlinson, J. W. (2016) · Metabolism · doi:10.1016/j.metabol.2016.01.001 · Cited by 527
The role of the microbiome in NAFLD and NASH
Kolodziejczyk, A. A., Zheng, D., Shibolet, O., & Elinav, E. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201809302 · Cited by 523
Song, Z., Cai, Y., Lao, X., Wang, X., Lin, X., Cui, Y., Kalavagunta, P. K., Liao, J., Jin, L., Shang, J., et al. (2019) · Microbiome · doi:10.1186/s40168-019-0628-3 · Cited by 505 · cited 2×
“The enzyme is mainly synthesized from Clostridium and Eubacterium species from the Firmicutes phylum [19].”
BackgroundCrane, J. D., Palanivel, R., Mottillo, E. P., Bujak, A. L., Wang, H., Ford, R. J., Collins, A., Blümer, R. M., Fullerton, M. D., Yabut, J. M., et al. (2015) · Nature Medicine · doi:10.1038/nm.3766 · Cited by 490
Wang, Y.-D., Chen, W.-D., Yu, D., Forman, B. M., & Huang, W. (2011) · Hepatology · doi:10.1002/hep.24525 · Cited by 480
Alisi, A., Bedogni, G., Baviera, G., Giorgio, V., Porro, E., Paris, C., Giammaria, P., Reali, L., Anania, F., & Nobili, V. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12758 · Cited by 471
Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance
Gaggini, M., Carli, F., Rosso, C., Buzzigoli, E., Marietti, M., Della Latta, V., Ciociaro, D., Abate, M. L., Gambino, R., Cassader, M., et al. (2018) · Hepatology · doi:10.1002/hep.29465 · Cited by 465
Bifidobacterium longum with Fructo-Oligosaccharides in Patients with Non Alcoholic Steatohepatitis
Malaguarnera, M., Vacante, M., Antic, T., Giordano, M., Chisari, G., Acquaviva, R., Mastrojeni, S., Malaguarnera, G., Mistretta, A., Li Volti, G., et al. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1887-4 · Cited by 455
Zhou, D., Pan, Q., Xin, F.-Z., Zhang, R.-N., He, C.-X., Chen, G.-Y., Liu, C., Chen, Y.-W., & Fan, J.-G. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i1.60 · Cited by 441
Zhou, D., Pan, Q., Shen, F., Cao, H.-X., Ding, W.-J., Chen, Y.-W., & Fan, J.-G. (2017) · Scientific Reports · doi:10.1038/s41598-017-01751-y · Cited by 421
Commensal bacteria-dependent indole production enhances epithelial barrier function in the colon
Shimada, Y., Kinoshita, M., Harada, K., Mizutani, M., Masahata, K., Kayama, H., & Takeda, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080604 · Cited by 404
Increased Liver Localization of Lipopolysaccharides in Human and Experimental NAFLD
Carpino, G., Del Ben, M., Pastori, D., Carnevale, R., Baratta, F., Overi, D., Francis, H., Cardinale, V., Onori, P., Safarikia, S., et al. (2020) · Hepatology · doi:10.1002/hep.31056 · Cited by 381
Nguyen, T. D. T., Kang, J. H., & Lee, M. S. (2007) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2006.08.015 · Cited by 376
Cope, K., Risby, T., & Diehl, A. M. (2000) · Gastroenterology · doi:10.1053/gast.2000.19267 · Cited by 357
Fasting-Mimicking Diet Promotes Ngn3-Driven β-Cell Regeneration to Reverse Diabetes
Cheng, C.-W., Villani, V., Buono, R., Wei, M., Kumar, S., Yilmaz, O. H., Cohen, P., Sneddon, J. B., Perin, L., & Longo, V. D. (2017) · Cell · doi:10.1016/j.cell.2017.01.040 · Cited by 331
Xue, L., He, J., Gao, N., Lu, X., Li, M., Wu, X., Liu, Z., Jin, Y., Liu, J., Xu, J., et al. (2017) · Scientific Reports · doi:10.1038/srep45176 · Cited by 305
Anderson, J. W., & Gilliland, S. E. (1999) · Journal of the American College of Nutrition · doi:10.1080/07315724.1999.10718826 · Cited by 302
Schwimmer, J. B., Johnson, J. S., Angeles, J. E., Behling, C., Belt, P. H., Borecki, I., Bross, C., Durelle, J., Goyal, N. P., Hamilton, G., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.06.028 · Cited by 298 · cited 2×
“Schwimmer et al. (2019) studied the gut microbiota in NAFLD children, reporting that NAFLD had lower alpha-diversity of gut microbiota compared with healthy controls, while NASH had the lowest alpha-diversity [10].”
BackgroundLactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice
Ritze, Y., Bárdos, G., Claus, A., Ehrmann, V., Bergheim, I., Schwiertz, A., & Bischoff, S. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0080169 · Cited by 292 · cited 2×
“(2014) demonstrated that LGG administration reduced gut inflammation by inhibiting NF-kB signalling pathway in a model of NAFLD with the mice fed on a fructose diet [79].”
BackgroundThe gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD
Soderborg, T. K., Clark, S. E., Mulligan, C. E., Janssen, R. C., Babcock, L., Ir, D., Young, B., Krebs, N., Lemas, D. J., Johnson, L. K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06929-0 · Cited by 288
Ji, Y., Gao, Y., Chen, H., Yin, Y., & Zhang, W. (2019) · Nutrients · doi:10.3390/nu11092062 · Cited by 288
Agreement Between 35 Published Frailty Scores in the General Population
Aguayo, G. A., Donneau, A.-F., Vaillant, M. T., Schritz, A., Franco, O. H., Stranges, S., Malisoux, L., Guillaume, M., & Witte, D. R. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx061 · Cited by 264
Hsieh, F.-C., Lee, C.-L., Chai, C.-Y., Chen, W.-T., Lu, Y.-C., & Wu, C.-S. (2013) · Nutrition & Metabolism · doi:10.1186/1743-7075-10-35 · Cited by 256
Hepatic TLR4 signaling in obese NAFLD
Sharifnia, T., Antoun, J., Verriere, T. G. C., Suarez, G., Wattacheril, J., Wilson, K. T., Peek, R. M., Abumrad, N. N., & Flynn, C. R. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00304.2014 · Cited by 245
Scorletti, E., Afolabi, P. R., Miles, E. A., Smith, D. E., Almehmadi, A., Alshathry, A., Childs, C. E., Del Fabbro, S., Bilson, J., Moyses, H. E., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.031 · Cited by 237
Sun, F., Wu, S., Wang, J., Guo, S., Chai, S., Yang, Z., Li, L., Zhang, Y., Ji, L., & Zhan, S. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.11.008 · Cited by 232
Anti-Obesity Effect of Lactobacillus gasseri BNR17 in High-Sucrose Diet-Induced Obese Mice
Kang, J.-H., Yun, S.-I., Park, M.-H., Park, J.-H., Jeong, S.-Y., & Park, H.-O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054617 · Cited by 230
Effects of fructans-type prebiotics on lipid metabolism
Delzenne, N. M., & Kok, N. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.456s · Cited by 225
The Plasma [Kynurenine]/[Tryptophan] Ratio and Indoleamine 2,3-Dioxygenase: Time for Appraisal
Badawy, A. A.-B., & Guillemin, G. (2019) · International Journal of Tryptophan Research · doi:10.1177/1178646919868978 · Cited by 224
Zhou, D., Chen, Y.-W., Zhao, Z.-H., Yang, R.-X., Xin, F.-Z., Liu, X.-L., Pan, Q., Zhou, H., & Fan, J.-G. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0183-1 · Cited by 217
Naito, E., Yoshida, Y., Makino, K., Kounoshi, Y., Kunihiro, S., Takahashi, R., Matsuzaki, T., Miyazaki, K., & Ishikawa, F. (2011) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2010.04922.x · Cited by 214
Weitkunat, K., Schumann, S., Petzke, K. J., Blaut, M., Loh, G., & Klaus, S. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.03.010 · Cited by 205
Wang, Y., Xu, N., Xi, A., Ahmed, Z., Zhang, B., & Bai, X. (2009) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-009-2012-x · Cited by 200
Effects of Intestinal Microbial–Elaborated Butyrate on Oncogenic Signaling Pathways
Chen, J., Zhao, K.-N., & Vitetta, L. (2019) · Nutrients · doi:10.3390/nu11051026 · Cited by 198
Self-citationZhou, Z.-L., Jia, X.-B., Sun, M.-F., Zhu, Y.-L., Qiao, C.-M., Zhang, B.-P., Zhao, L.-P., Yang, Q., Cui, C., Chen, X., et al. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00719-2 · Cited by 195
Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease
Saltzman, E. T., Palacios, T., Thomsen, M., & Vitetta, L. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00061 · Cited by 193
Self-citationLake, A. D., Novak, P., Shipkova, P., Aranibar, N., Robertson, D., Reily, M. D., Lu, Z., Lehman-McKeeman, L. D., & Cherrington, N. J. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.01.022 · Cited by 189
Tryptophan Metabolic Pathways Are Altered in Obesity and Are Associated With Systemic Inflammation
Cussotto, S., Delgado, I., Anesi, A., Dexpert, S., Aubert, A., Beau, C., Forestier, D., Ledaguenel, P., Magne, E., Mattivi, F., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00557 · Cited by 189
Pathogenesis and novel treatment options for non-alcoholic steatohepatitis
Wong, V. W.-S., Chitturi, S., Wong, G. L.-H., Yu, J., Chan, H. L.-Y., & Farrell, G. C. (2016) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30011-5 · Cited by 185
The Role of Butyrate in Attenuating Pathobiont-Induced Hyperinflammation
Chen, J., & Vitetta, L. (2020) · Immune Network · doi:10.4110/in.2020.20.e15 · Cited by 181
Self-citationKim, D.-H., Kim, H., Jeong, D., Kang, I.-B., Chon, J.-W., Kim, H.-S., Song, K.-Y., & Seo, K.-H. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.02.014 · Cited by 179
Short-Chain Fatty Acid Receptor and Its Contribution to Glucagon-Like Peptide-1 Release
Kaji, I., Karaki, S.-I., & Kuwahara, A. (2014) · Digestion · doi:10.1159/000356211 · Cited by 177
Haroon, E., Welle, J. R., Woolwine, B. J., Goldsmith, D. R., Baer, W., Patel, T., Felger, J. C., & Miller, A. H. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0607-1 · Cited by 171
Fei, N., Bruneau, A., Zhang, X., Wang, R., Wang, J., Rabot, S., Gérard, P., & Zhao, L. (2020) · mBio · doi:10.1128/mbio.03263-19 · Cited by 168
Alvarez-Sola, G., Uriarte, I., Latasa, M. U., Fernandez-Barrena, M. G., Urtasun, R., Elizalde, M., Barcena-Varela, M., Jiménez, M., Chang, H. C., Barbero, R., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312975 · Cited by 164
Serotonin signals through a gut-liver axis to regulate hepatic steatosis
Choi, W., Namkung, J., Hwang, I., Kim, H., Lim, A., Park, H. J., Lee, H. W., Han, K.-H., Park, S., Jeong, J.-S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07287-7 · Cited by 161
Ma, L., Li, H., Hu, J., Zheng, J., Zhou, J., Botchlett, R. E., Matthews, D., Zeng, T., Chen, L., Xiao, X., et al. (2020) · Hepatology · doi:10.1002/hep.31115 · Cited by 161
Chiu, C.-C., Ching, Y.-H., Li, Y.-P., Liu, J.-Y., Huang, Y.-T., Huang, Y.-W., Yang, S.-S., Huang, W.-C., & Chuang, H.-L. (2017) · Nutrients · doi:10.3390/nu9111220 · Cited by 160
Chen, J., Thomsen, M., & Vitetta, L. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27635 · Cited by 159
Self-citationInsulin resistance and the metabolism of branched-chain amino acids in humans
Adeva, M. M., Calviño, J., Souto, G., & Donapetry, C. (2012) · Amino Acids · doi:10.1007/s00726-011-1088-7 · Cited by 158
Xin, J., Zeng, D., Wang, H., Ni, X., Yi, D., Pan, K., & Jing, B. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-014-5752-1 · Cited by 155
Kim, B., Park, K.-Y., Ji, Y., Park, S., Holzapfel, W. H., & Hyun, C. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.03.107 · Cited by 150
Inflammation-Modulating Effect of Butyrate in the Prevention of Colon Cancer by Dietary Fiber
Chen, J., & Vitetta, L. (2018) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2018.05.001 · Cited by 150
Self-citationZhao, Z., Chen, L., Zhao, Y., Wang, C., Duan, C., Yang, G., Niu, C., & Li, S. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10633-9 · Cited by 147
Engstler, A. J., Aumiller, T., Degen, C., Dürr, M., Weiss, E., Maier, I. B., Schattenberg, J. M., Jin, C. J., Sellmann, C., & Bergheim, I. (2015) · Gut · doi:10.1136/gutjnl-2014-308379 · Cited by 140
Wolowczuk, I., Hennart, B., Leloire, A., Bessede, A., Soichot, M., Taront, S., Caiazzo, R. J., Raverdy, V., Pigeyre, M., Guillemin, G. J., et al. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00373.2011 · Cited by 130
Dietary oligofructose modifies the impact of fructose on hepatic triacylglycerol metabolism
Kok, N. N., Roberfroid, M., & Delzenne, N. M. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90186-9 · Cited by 130
Lactobacillus casei Shirota protects from fructose-induced liver steatosis: A mouse model
Wagnerberger, S., Spruss, A., Kanuri, G., Stahl, C., Schröder, M., Vetter, W., Bischoff, S. C., & Bergheim, I. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.01.014 · Cited by 125
Okubo, H., Sakoda, H., Kushiyama, A., Fujishiro, M., Nakatsu, Y., Fukushima, T., Matsunaga, Y., Kamata, H., Asahara, T., Yoshida, Y., et al. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00225.2013 · Cited by 119
Sunny, N. E., Kalavalapalli, S., Bril, F., Garrett, T. J., Nautiyal, M., Mathew, J. T., Williams, C. M., & Cusi, K. J. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00161.2015 · Cited by 117
Role of farnesoid X receptor in hepatic steatosis in nonalcoholic fatty liver disease
Xi, Y., & Li, H. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109609 · Cited by 117
Wei, S., Han, R., Zhao, J., Wang, S., Huang, M., Wang, Y., & Chen, Y. (2018) · Nutrition & Metabolism · doi:10.1186/s12986-018-0318-3 · Cited by 114
Chen, X., Zhang, Z., Li, H., Zhao, J., Wei, X., Lin, W., Zhao, X., Jiang, A., & Yuan, J. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15027 · Cited by 109
Naudin, C. R., Maner-Smith, K. M., Owens, J. A., Wynn, G. M., Robinson, B. S., Matthews, J. D., Reedy, A. R., Luo, L., Wolfarth, A. A., Darby, T. M., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.03.010 · Cited by 109
Chiang, J. Y. L., Pathak, P., Liu, H., Donepudi, A. C., Ferrell, J. M., & Boehme, S. (2017) · Digestive Diseases · doi:10.1159/000450981 · Cited by 108
Liu, L., Li, P., Liu, Y., & Zhang, Y. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05699-z · Cited by 104
Asghari, S., Jafarabadi, M. A., Somi, M. H., Ghavami, S.-M., & Rafraf, M. (2018) · Journal of the American College of Nutrition · doi:10.1080/07315724.2017.1392264 · Cited by 100
Effect of tryptophan supplementation on diet-induced non-alcoholic fatty liver disease in mice
Ritze, Y., Bárdos, G., Hubert, A., Böhle, M., & Bischoff, S. C. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114514000440 · Cited by 93
Currier, A. R., Ziegler, M., Riley, M., Babcock, T., Telbis, V. P., & Carlin, J. (2000) · Journal of Interferon and Cytokine Research · doi:10.1089/107999000312306 · Cited by 92
Systematic Review with Meta-Analysis: The Effects of Probiotics in Nonalcoholic Fatty Liver Disease
Xiao, M.-W., Lin, S., Shen, Z., Luo, W., & Wang, X. (2019) · Gastroenterology Research and Practice · doi:10.1155/2019/1484598 · Cited by 90
Matsumoto, K., Ichimura‐Shimizu, M., Tsuneyama, K., Moritoki, Y., Tsunashima, H., Omagari, K., Hara, M., Yasuda, I., Miyakawa, H., & Kikuchi, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175406 · Cited by 88
β-Klotho gene variation is associated with liver damage in children with NAFLD
Dongiovanni, P., Crudele, A., Panera, N., Romito, I., Meroni, M., Stefanis, C. D., Palma, A., Comparcola, D., Fracanzani, A. L., Miele, L., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.011 · Cited by 81
Lü, M., Tang, Y., Li, M., Yang, P., Liu, Z., Yuan, J., & Zheng, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138078 · Cited by 80
Yao, F., Jia, R., Huang, H., Yu, Y. Q., Lü, M., Bai, L., Ding, Y., & Zheng, P. (2019) · Archives of Medical Science · doi:10.5114/aoms.2019.86611 · Cited by 76
Probiotic culture supernatant improves metabolic function through FGF21-adiponectin pathway in mice
Liu, Q., Liu, Y., Li, F., Gu, Z., Liu, M., Shao, T., Zhang, L., Zhou, G., Pan, C., He, L., et al. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.108256 · Cited by 76
Chong, C. Y. L., Orr, D. W., Plank, L. D., Vatanen, T., O'Sullivan, J. M., & Murphy, R. (2020) · Nutrients · doi:10.3390/nu12040937 · Cited by 72
Park, E., Lee, Y., Kim, S. M., Park, G.-S., Lee, Y. H., Jeong, D. Y., Kang, J., & Lee, H. (2020) · Nutrients · doi:10.3390/nu12020542 · Cited by 71
Schumacher, J. D., & Guo, G. L. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_228 · Cited by 67
Takai, A., Kikuchi, K., Ichimura‐Shimizu, M., Tsuneyama, K., Moritoki, Y., Matsumoto, K., Tsunashima, H., Onda, T., Kuniyoshi, N., Nariyama, T., et al. (2020) · BMC Gastroenterology · doi:10.1186/s12876-020-01194-2 · Cited by 67
Onoviran, O. F., Li, D., Smith, S. T., & Raji, M. A. (2019) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622319862691 · Cited by 66
Probiotics VSL#3 are effective in reversing non-alcoholic steatohepatitis in a mouse model
Jena, P. K., Sheng, L., Li, Y., & Wan, Y.-J. Y. (2020) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn.2019.09.07 · Cited by 61
Probiotics modify tight-junction proteins in an animal model of nonalcoholic fatty liver disease
Briskey, D. R., Heritage, M. L., Jaskowski, L., Peake, J. M., Gobe, G. C., Subramaniam, V. N., Crawford, D. H., Campbell, C. M., & Vitetta, L. (2016) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x16645055 · Cited by 58
Self-citationAlves, C. C., Waitzberg, D. L., de Andrade, L. S., Aguiar, L. D. S., Reis, M. B., Guanabara, C. C., Aguiar, O., Ribeiro, D. A., & Sala, P. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02010 · Cited by 58
Sohn, W., Jun, D. W., Lee, K. N., Lee, H. L., Lee, O. Y., Choi, H. S., & Yoon, B. C. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3770-1 · Cited by 56
Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis
Baumann, A., Jin, C. J., Brandt, A., Sellmann, C., Nier, A., Burkard, M., Venturelli, S., & Bergheim, I. (2020) · Nutrients · doi:10.3390/nu12040951 · Cited by 52
Chen, J., Zheng, M., Liu, J., Luo, Y., Yang, W., Yang, J., Liu, J., Jingxing, Z., Xu, C., Zhao, F., et al. (2019) · Obesity · doi:10.1002/oby.22627 · Cited by 49
Self-citationHernandez, G. V., Smith, V. A., Melnyk, M., Burd, M. A., Sprayberry, K. A., Edwards, M. S., Peterson, D. G., Bennet, D. C., Fanter, R. K., Columbus, D. A., et al. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00344.2019 · Cited by 44 · cited 3×
“(2020) reported that high fructose-, fat- and cholesterol feeding in pigs caused hepatic steatosis and inflammation, with impaired FXR-FGF19 signaling [65].”
BackgroundButyrate in Inflammatory Bowel Disease Therapy
Chen, J., & Vitetta, L. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.08.064 · Cited by 44
Self-citationHissong, B., & Carlin, J. M. (1997) · Journal of Interferon and Cytokine Research · doi:10.1089/jir.1997.17.387 · Cited by 41
Mitochondria could be a potential key mediator linking the intestinal microbiota to depression
Chen, J., & Vitetta, L. (2020) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29311 · Cited by 36
Self-citationTaurine attenuates hepatic steatosis in a genetic model of fatty liver disease
Miyata, M., Funaki, A., Fukuhara, C., Sumiya, Y., & Sugiura, Y. (2020) · The Journal of Toxicological Sciences · doi:10.2131/jts.45.87 · Cited by 35
Piirsalu, M., Taalberg, E., Lilleväli, K., Tian, L., Zilmer, M., & Vasar, E. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00371 · Cited by 33
Arao, Y., Kawai, H., Kamimura, K., Kobayashi, T., Nakano, O., Hayatsu, M., Ushiki, T., & Terai, S. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.03.180 · Cited by 27
Haubert, N. J. B. G. B., Marchini, J. S., Cunha, S. F. C., Suen, V. M. M., Padovan, G. J., Jordão, A. A., Alves, C. M. M. M., Marchini, J. F. M., & Vannucchi, H. (2015) · Nutrition and Metabolic Insights · doi:10.4137/nmi.s24385 · Cited by 26
Nseir, W., Artul, S., Nasrallah, N., & Mahamid, M. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.10.004 · Cited by 20
Sofi, F. (2020) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2020.1746959 · Cited by 18
Bile acids and butyrate in the effects of probiotics/synbiotics on nonalcoholic fatty liver disease
Chen, J., & Vitetta, L. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001506 · Cited by 13
Self-citationLouala, S., & Lamri‐Senhadji, M. (2019) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2019.24.4.400 · Cited by 10
Chen, J., & Vitetta, L. (2020) · Hepatology · doi:10.1002/hep.31269 · Cited by 10
Self-citation
Cited by
Gut liver brain axis in diseases: the implications for therapeutic interventions
Yan, M., Man, S., Sun, B., Ma, L., Guo, L., Huang, L., & Gao, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01673-4 · Cited by 287
In Vitro Models for Non-Alcoholic Fatty Liver Disease: Emerging Platforms and Their Applications
Ramos, M. J., Bandiera, L., Menolascina, F., & Fallowfield, J. A. (2022) · iScience · doi:10.1016/j.isci.2021.103549 · Cited by 127
Specificity Influences in (1→3)-β-d-Glucan-Supported Diagnosis of Invasive Fungal Disease
Finkelman, M. A. (2020) · Journal of Fungi · doi:10.3390/jof7010014 · Cited by 76
Metadata
- Authors
- Chen, J., & Vitetta, L.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-07-23
- Volume
- 21
- Issue
- 15
- Pages
- 5214
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3044264576
- Cited by
- 352
- References
- 116
- FWCI
- 9.40
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.